Clinical Trial

FOLFOXIRI-based HAIC Combined With Fuquintinib as Late-line Treatment in Patients With CRLM：A Phase 2 Single-Arm Clinical Trial

Study acronym: HAIC，CRLM
Completed Phase 2
View on ClinicalTrials.gov →
Summary
This study was a phase 2, single-arm, single-center clinical trial in which previously treated patients with unresectable colorectal cancer liver metastases.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-12.
Status change: Active, Not Recruiting → Completed 2026-04-26
Trial Details
NCT Number NCT07024537
Lead Sponsor Meng Qiu
Conditions Colorectal Neoplasms
Enrollment 44 participants
Start Date 2023-01-12
Primary Completion 2025-05-30 (estimated)
Study Completion 2025-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-30